CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
886-900 of 1225
Pulmonary Hypertension Management: Practice Trends and Updates
CME/CE Broadcast ReplayPulmonary Hypertension Management: Practice Trends and Updates
Vallerie V. McLaughlin, MD
Victor Moles, MD
Ioana Preston, MD
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
CME/CEAdvances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Naim Alkhouri, MD, FAASLD, DABOM
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
MinuteCE®Autoantibodies in CIDP: Prevalence and Diagnostic Implications
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
MinuteCE®Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
MinuteCE®Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
Nicholas J. Silvestri, MD
Jeffrey Allen, MD
Case Application: Adverse Event Management of Patients With EGFRm Resistance Treated With Novel HER3-Directed ADCs
MinuteCE®Case Application: Adverse Event Management of Patients With EGFRm Resistance Treated With Novel HER3-Directed ADCs
Helena Yu, MD
Pasi Antero Jänne, MD, PhD
- advertisement
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
MinuteCE®Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Decoding CIDP: Exploring Common and Atypical Variants
MinuteCE®Decoding CIDP: Exploring Common and Atypical Variants
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
MinuteCE®Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
MinuteCE®CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Biologic Rationale for Targeting HER3 and Role in EGFR Resistance
MinuteCE®Biologic Rationale for Targeting HER3 and Role in EGFR Resistance
Pasi Antero Jänne, MD, PhD
Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy
MinuteCE®Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
- advertisement
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
MinuteCE®Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
Helena Yu, MD
Pasi Antero Jänne, MD, PhD
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective
CME/CEThe Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective
Naim Alkhouri, MD, FAASLD, DABOM
Implementing CIDP Clinical Guidelines: Optimizing Therapy
MinuteCE®Implementing CIDP Clinical Guidelines: Optimizing Therapy
Nicholas J. Silvestri, MD
Jeffrey Allen, MD
